Pesquet Anthony, Daïch Adam, Van Hijfte Luc
URCOM, EA 3221, UFR des Sciences & Techniques, Université du Havre, 25 rue Philippe Lebon, B.P. 540, F-76058 Le Havre Cedex, France.
J Org Chem. 2006 Jul 7;71(14):5303-11. doi: 10.1021/jo060616s.
A simple and efficient methodology for the synthesis of 4,5-fused imidazolidin-2-ones from bicyclic and tricyclic ketones in a four-step sequence was described, by successive spirohydantoin Bucherer-Berg formation, mono- and dialkylation of the nitrogen atom of the hydantoin ring, regioselective reduction of one carbonyl function, and cationic cyclization associated with ring expansion. The key step of this sequential reaction was based on a tandem transposition/intramolecular amidoalkylation of cyclic spiro-N-acyliminium species. The process seems to be easy, general, regiospecific, resulted in the formation of polyheterocyclic systems containing an imidazolidin-2-one nucleus in good to excellent yields (67-99%), and is compatible with a large-scale production (up to 3 g of product 14, for example). Also, this method allows the preparation of the novel heterocycles 14 and 15 that have pharmaceutically interesting profiles, which are not accessible through short current synthetic methods. Finally, products 15 bear a secondary amide function crucial for further transformations, including the introduction of various pharmacophore groups either at the C or the N atoms of the imidazole ring.
描述了一种简单有效的方法,通过连续的螺内酰胺布赫勒-贝格反应、内酰胺环氮原子的单烷基化和二烷基化、一个羰基官能团的区域选择性还原以及与环扩张相关的阳离子环化反应,以四步序列从双环和三环酮合成4,5-稠合咪唑烷-2-酮。该连续反应的关键步骤基于环状螺-N-酰基亚胺离子物种的串联转位/分子内酰胺烷基化。该过程似乎简单、通用、区域特异性强,能以良好至优异的产率(67-99%)形成含有咪唑烷-2-酮核的多杂环体系,并且与大规模生产兼容(例如,可生产高达3 g的产物14)。此外,该方法允许制备具有药学意义的新型杂环14和15,而这些杂环无法通过当前的短合成方法获得。最后,产物15带有一个对进一步转化至关重要的仲酰胺官能团,包括在咪唑环的C或N原子处引入各种药效基团。